Gene: NIPAL2
Official Full Name: NIPA like domain containing 2provided by HGNC
Gene Summary: Predicted to enable magnesium ion transmembrane transporter activity. Predicted to be involved in magnesium ion transport. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15736 | NIPAL2 Knockout cell line (HeLa) | Human | NIPAL2 | 1:3~1:6 | Negative | Online Inquiry |
KO15737 | NIPAL2 Knockout cell line (HCT 116) | Human | NIPAL2 | 1:2~1:4 | Negative | Online Inquiry |
KO15738 | NIPAL2 Knockout cell line (HEK293) | Human | NIPAL2 | 1:3~1:6 | Negative | Online Inquiry |
KO15739 | NIPAL2 Knockout cell line (A549) | Human | NIPAL2 | 1:3~1:4 | Negative | Online Inquiry |
NIPAL2 Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to facilitate the study of the NIPAL2 gene, which has been implicated in various physiological processes and diseases, including metabolic disorders and neurodegenerative conditions. By employing CRISPR-Cas9 technology, these cell lines feature precise deletions of the NIPAL2 gene, allowing researchers to investigate the functional role of this gene in cellular pathways and its implications in pathology.
The primary function of NIPAL2 Gene Knockout Cell Lines lies in providing a controlled environment for the evaluation of gene function and the resultant phenotypic changes due to gene disruption. Through loss-of-function studies, researchers can elucidate the molecular mechanisms underlying NIPAL2’s involvement in disease states, paving the way for potential therapeutic targets. These cell lines enable the examination of cellular responses, signaling pathways, and biomarker expression in a manner that mimics in vivo conditions.
From a scientific standpoint, the ability to utilize NIPAL2 knockout models is invaluable in both basic research settings and clinical applications, particularly given the gene’s link to critical metabolic processes. As such, these models serve as vital tools in drug discovery, genetic research, and the development of innovative treatment strategies for conditions stemming from NIPAL2 dysregulation.
In comparison to traditional knockout models, the NIPAL2 Gene Knockout Cell Lines are noted for their ease of use, reproducibility, and ability to be customized to various experimental conditions. Researchers benefit from the consistent genetic profiles and the availability of related resources to enhance experimental accuracy.
For researchers and clinicians alike, NIPAL2 Gene Knockout Cell Lines present an essential resource, enabling comprehensive investigations into genetic mechanisms and therapeutic potential for diseases linked to NIPAL2. With a strong track record in developing advanced biological products, our company is committed to supporting the scientific community with high-quality tools that drive meaningful research solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.